ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 198 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $647,000 | +18.1% | 87,600 | -0.1% | 0.01% | 0.0% |
| Q4 2015 | $548,000 | +262.9% | 87,700 | +381.9% | 0.01% | +200.0% |
| Q2 2015 | $151,000 | -81.4% | 18,200 | -81.5% | 0.00% | -80.0% |
| Q1 2015 | $811,000 | -38.3% | 98,400 | -52.3% | 0.01% | -50.0% |
| Q2 2014 | $1,315,000 | +34.9% | 206,400 | +70.6% | 0.02% | +17.6% |
| Q1 2014 | $975,000 | +56.2% | 121,000 | +32.2% | 0.02% | +70.0% |
| Q4 2013 | $624,000 | +228.4% | 91,500 | +744.1% | 0.01% | +150.0% |
| Q2 2013 | $190,000 | – | 10,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |